News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  21 November 2014  
  Cbfb deficiency results in differentiation blocks and stem/progenitor cell expansion in hematopoiesis
 
 




Authors
Chelsia Qiuxia Wang1,2,7, Desmond Wai Loon Chin1,7, Jing Yuan Chooi1,7, Chng Wee Joo1, Ichiro Taniuchi3, Vinay Tergaonkar2*, Motomi Osato1,7.*

1  Cancer Science Institute of Singapore, National University of Singapore, Singapore;
2  Institute of Molecular and Cell Biology, Singapore;
3  RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
4  Institute of Bioengineering and Nanotechnology, Singapore

7  These authors contributed equally to this work.

*Corresponding Authors: Vinay Tergaonkar, vinayt@imcb.a-star.edu.sg, Institute of Molecular and Cell Biology, A*STAR, 61 Biopolis Drive, Singapore 138673.  Tel: +65-6601-1442.  Fax: +65-6873-9664.

Motomi Osato, MD, csimo@nus.edu.sg, Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599,


Published in Leukemia, 5 November 2014; doi: 10.1038/leu.2014.316

This article has been recommended in F1000Prime as being of special significance in its field. Please see http://f1000.com/prime/718885762?ref=ypp

Abstract

The PEBP2/CBF heterodimeric transcription factors consist of two subunits: a DNA-binding α subunit (Runx1, Runx2 or Runx3) and a non-DNA-binding β subunit (PEBP2b/Cbfβ) encoded by Cbfb. RUNX1 and CBFB play critical roles in hematopoiesis and are frequently mutated in human leukemia. Similar to Runx1-/- mice, Cbfb-/- embryos die at midgestation due to hemorrhage and complete lack of hematopoietic stem cells (HSCs). Due to this embryonic lethality, Cbfb function in adult hematopoiesis remains unknown. Here, we show that Cbfb conditional knockout (cKO) mice exhibited differentiation blockages and HSC expansion that are more drastic than Runx1 cKO mice. Notably, such precancerous status was more pronounced when Cbfb was inactivated at neonatal stage by using Vav-iCre system, as compared to that at adult stage by Mx-Cre system. This age-dependent phenotypic enhancement may underlie the high prevalence of human RUNX leukemia in childhood and younger adults.

Figure Legend: Schematic diagram showing hematological phenotypes in Cbfb cKO mice.

(A) Differentiation blocks (lines) at specific developmental stages in multiple lineages and resultant relative increase of immediate upstream population (arrows) in the Cbfb cKO mice are shown. The size of arrow represents the magnitude of changes. The differentiation blocks led to the failure in production of mature cells of various lineages (arrows within yellow box). Changes in the HSPC compartments are also indicated (arrows). Blue, Cbfbfl/fl;Mx1-Cre+; red, Cbfbfl/fl;Vav-iCre+; green, Cbfb cKO.

(B) Diagram showing the window within which Cbfb is indispensable at the developmental stage and within which Cbfb is dispensable at the adult stage. Top, cell cycle status of HSCs is indicated. Bottom, the time when Vav-iCre or Mx1-Cre are expressed in hematopoietic tissues are depicted.

For more information about the laboratory of Vinay TERGAONKAR, please click here.